Food and Fitness With Medicine (FFWM)
Food and Fitness With Medicine
Ohio State University
200 participants
Jan 14, 2026
INTERVENTIONAL
Conditions
Summary
Food and Fitness with Medicine (FFWM) is a 24-week randomized controlled trial (RCT) enrolling 200 post-menopausal women (PMW) with stage 2 cardio-kidney metabolic (CKM) syndrome and type-2 diabetes (T2D) within 6 weeks of initiating glucagon-like peptide-1 receptor agonist (GLP-1RAs) to: 1. Examine discontinuation rates of GLP-1RAs (primary outcome); 2. Compare change in American Heart Association (AHA) PREVENT scores (secondary outcome); and 3. Examine the effects of FFWM on biologic mechanisms responsive to weight loss and cardiovascular health (CVH) including dermal carotenoids, body composition and metabolite biomarkers.
Eligibility
Plain Language Summary
Simplified for easier understanding
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
During Phase 1 (Weeks 1-12), participants are enrolled in a comprehensive 12-week fitness education and training program.
During Phase 1 \& 2, participants receive monthly hybrid cooking demonstrations with culinary training.
During Phase 1 (Weeks 1-12), participants receive bi-weekly medically tailored grocery vouchers.
During Phase 1 (Weeks 1-12), participants engage in weekly behavioral nutrition counseling.
During Phases 1 and 2, participants will receive digital behavioral reinforcers and access to a secure web portal that provides evidence-based resources.
Locations(4)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07027995